The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 413.50
Bid: 414.00
Ask: 418.00
Change: 6.00 (1.47%)
Spread: 4.00 (0.966%)
Open: 411.00
High: 419.00
Low: 411.00
Prev. Close: 407.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - BCA Marketplace plc

23 Jul 2019 16:32

RNS Number : 4733G
Banco Santander S.A.
23 July 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Banco Santander S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BCA Marketplace plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19/07/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,000,000

1.1475

 

 

(2) Cash-settled derivatives:

 

 

 

9,000,000

1.1475

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

9,000,000

1.1475

9,000,000

1.1475

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

4,000,000

2.43 GBP

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

Total Return Swap

Increasing short position

4,000,000

2.43 GBP

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23 July 2019

Contact name:

Laura Sweeney

Telephone number:

07885 822 104

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETRJMATMBJTBML
Date   Source Headline
30th Nov 20226:20 pmRNSTotal Voting Rights
21st Nov 20222:07 pmRNSCommencement of a program to repurchase own shares
26th Oct 202211:09 amRNSForm 8.3 - HomeServe Plc
26th Oct 20227:00 amRNS3rd Quarter 2022 Results
26th Oct 20227:00 amRNS3rd Quarter 2022 Results - Press release
21st Oct 20227:00 amRNSTender Offer
19th Oct 20223:04 pmRNSNotice of Third Quarter 2022 Results
27th Sep 20226:19 pmRNSDividend Declaration
27th Sep 20225:16 pmRNSHalf-year Report
22nd Sep 20228:36 amRNSForm 8.3 - HomeServe plc
30th Aug 20227:36 amRNSForm 8.3 - Meggitt plc
4th Aug 202211:50 amRNSDirector/PDMR Shareholding
28th Jul 20227:13 amRNS1H2022 results report & analyst presentation
28th Jul 20227:00 amRNSFirst half 2022 results press release
27th Jul 20223:02 pmRNSNotice of First Half 2022 Results
22nd Jul 20227:04 amRNSCitigroup, Inc. process in Mexico
8th Jul 20227:00 amRNSInformation to bondholders
1st Jul 20222:09 pmRNSFurther re Capital reduction
30th Jun 20226:41 pmRNSTotal Voting Rights
29th Jun 202211:16 amRNSRedemption and cancellation of territorial bonds
28th Jun 20225:24 pmRNSCapital Reduction (2022 buy-back programme shares)
17th Jun 20229:38 amRNSDirectorate Change (Conference call)
17th Jun 20227:00 amRNSDirectorate Change
13th Jun 20223:26 pmRNSDirector/PDMR Shareholding
10th Jun 202211:34 amRNSTotal redemption and cancellation of covered bonds
6th Jun 20227:00 amRNSTotal redemption and cancellation of covered bonds
20th May 202212:19 pmRNSSantander informs of the MREL determined by SRB
6th May 20223:29 pmRNSEnd of the Programme & 28 Apr - 6 May Transactions
6th May 20222:48 pmRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSTotal Voting Rights
29th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Apr 20229:40 amRNSDirector/PDMR Shareholding
28th Apr 202211:12 amRNSBuyback programme: transactions 19 - 27 April
26th Apr 20224:54 pmRNSFurther re Capital reduction
26th Apr 20227:00 amRNS1Q2022 results report & analyst presentation
26th Apr 20227:00 amRNS1st Quarter 2022 Results - Press release
25th Apr 20223:04 pmRNSNotice of First Quarter 2022 Results
21st Apr 202211:48 amRNSForm 8.3 - Meggitt plc
19th Apr 202211:43 amRNSTransaction in Own Shares
7th Apr 202211:41 amRNSBuyback programme: transactions 31 March - 6 April
4th Apr 20225:39 pmRNSNew financial reporting
1st Apr 20225:57 pmRNSCapital reduction (2021 buy-back programme shares)
1st Apr 20224:30 pmRNS2022 AGM - Resolutions
1st Apr 20227:00 amRNSSantander confirms its financial targets for 2022
1st Apr 20227:00 amRNS2021 UK Annual Report
31st Mar 202211:33 amRNSBuyback programme: transactions 24 - 30 March
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.